Search 
FAQs & How to use this site
Home | About Us | Contact Us
View Protocol Abstract: S9205
Search All Protocols  Search Open Protocols  Search Closed Protocols  Search Published Protocols  View Search Results

The links after "Participants" show which Southwest Oncology Group institutions are eligible to participate in this study.

The orange "Where is This Study Open?" tab at the bottom of the page shows the institutions whose Institutional Review Boards (IRBs) have approved the protocol so that it can be opened at that institution. Clicking on the Institution Name will show the points of contact for information about this study at that institution.

SWOG-9205 - Ancillary(Closed)
Central Prostate Cancer Serum Repository Protocol
Disease Committee: Genitourinary Cancer
Study Coordinator(s): Mitchell C. Benson, M.D., Daniel P. Petrylak, M.D., Wael A. Sakr, M.D., E. David Crawford, M.D., Paul H. Gumerlock, Ph.D.

Participants: Members, CCOP, UCOP, Affiliates, Medical Oncologists, Surgeons, Pathologists

Eligibility Criteria: Pt must be eligible for and registered to a SWOG protocol for carcinoma of the prostate. Pts must submit greater than/equal to 3 ml of unthawed serum from baseline.

Activation Date: 10/1/1992
Closure Date: 10/1/2006

line
 
     
SWOG Logo Disclaimer | Copyright ©2000-2010 SWOG. All rights reserved.
Design by nuMedia Group Inc. | Hosting by WorldPost Technologies, Inc.
SWOG is FISMA CertifiedSWOG is FISMA Certified